Skip to content
The Cancer History Project
HOME
ABOUT
THE CANCER HISTORY PROJECT
THE CANCER LETTER
EDITORIAL BOARD
SPONSORS
CONTRIBUTORS
TCL ARCHIVES
LATEST ARTICLES
Search for:
Search
ARCHIVES
Also in this 8-page issue: Richard Pazdur named director of FDA’s new Office of Oncology Drug Products.
This article is from
The Cancer Letter
archive.
Vol. 31 No. 16 | April 22, 2005
Download PDF
Visit The Full Archive
Related Articles
TCL Archive
New Research Grant Awards
December 13, 1974
TCL Archive
Center Core Grants Could Face Cuts Of Up To 20%
February 16, 1990
TCL Archive
Hammer Says He’ll Ask Reagan For Bigger NCI Budget
October 30, 1981
TCL Archive
Study Identifies Characteristics That Promote Early-Life NHL
May 25, 2012
TCL Archive
Porter Softens Proposal To require SBIR Scores To Match R01s
July 26, 1996
TCL Archive
Mammography’s Best Role Is Screening, Kopans Assert
March 18, 1994